Online:
Visits:
Stories:
Profile image
By marketresearchnest
Contributor profile | More stories
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Rotavirus Infections Therapeutics Pipeline Market H1 2017

Thursday, May 18, 2017 5:39
% of readers think this story is Fact. Add your two cents.

(Before It's News)

MarketResearchNest.com adds “Rotavirus Infections – Pipeline Review, H1 2017” new report to its research database. The report spread across in multiple pages with table and figures in it.

 

Latest Pharmaceutical and Healthcare disease pipeline guide Rotavirus Infections – Pipeline Review, H1 2017, provides an overview of the Rotavirus Infections (Infectious Disease) pipeline landscape.

Rotavirus is a virus that infects the bowels. Rotavirus is the most common cause of severe diarrhea among infants and children. Transmission of rotavirus most often occurs through fecal-oral contact. Usually, this occurs from poor hand washing or from ingestion of contaminated food or water. The virus may also be transmitted through the respiratory tract or by other body fluids, but these routes are less common. The virus may live on inanimate surfaces, such as doorknobs, toys, and hard surfaces. Symptoms may include severe diarrhea, vomiting, fever, and dehydration.

Browse full table of contents and data tables at https://www.marketresearchnest.com/rotavirus-infections-pipeline-review-h1-2017.html

The Rotavirus Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Rotavirus Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 3, 1, 1, 5 and 2 respectively. Similarly, the Universities portfolio in Phase II and Discovery stages comprises 4 and 1 molecules, respectively.

Rotavirus Infections (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

 

Rotavirus Infections – Companies Involved in Therapeutics Development

Beijing Minhai Biotechnology Co Ltd

Bharat Biotech International Ltd

Biological E Ltd

Curevac AG

Medicago Inc

Nanotherapeutics Inc

Serum Institute of India Ltd

Shantha Biotechnics Ltd

Takeda Pharmaceutical Company Ltd

Wuhan Institute of Biological Products Co Ltd

 

Order a Purchase Report Copy at https://www.marketresearchnest.com/purchase.php?reportid=205665

 

Featured News & Press Releases
May 12, 2014: Gene Signal announces positive data from Phase III trial of aganirsen eye drops for Sep 21, 2016: Batavia Biosciences receives grant to develop new vaccine against rotavirus
Oct 14, 2014: Shantha`s Investigational Rotavirus Vaccine Enters Phase III Clinical Trials in India
Jun 20, 2013: Medicago Successfully Produces Plant-based Rotavirus VLP Vaccine Candidate
Nov 10, 2012: GSK’s Rotarix Vaccine To Help Protect Babies Against Rotavirus
Apr 26, 2012: GSKs Rotarix To Be Introduced In Ghana
Nov 21, 2011: GSK And Daiichi Sankyo To Launch Rotarix Oral Liquid Formulation To Prevent Rotavirus Gastroenteritis In Japan
May 19, 2010: Health Sciences Authority Provides Update On Review Of Presence Of Porcine Circovirus In GSK’s Rotarix

 

Scope of this Report

- The pipeline guide provides a snapshot of the global therapeutic landscape of Rotavirus Infections (Infectious Disease).
- The pipeline guide reviews pipeline therapeutics for Rotavirus Infections (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Rotavirus Infections (Infectious Disease) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Rotavirus Infections (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Rotavirus Infections (Infectious Disease)

 

Request Sample Copy at https://www.marketresearchnest.com/requestsample.php?reportid=205665

 

About Us:                         

MarketResearchNest.com is the most comprehensive collection of market research products and services on the Web. We offer reports from almost all top publishers and update our collection on daily basis to provide you with instant online access to the world’s most complete and recent database of expert insights on global industries, organizations, products, and trends.

 

Contact Us

Mr. Jeet Jain

Sales Manager

[email protected]

+1-240-284-8070

Connect with us:  Google+ | LinkedIn | Twitter | Facebook

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories
 

Featured

 

Top Global

 

Top Alternative

 

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.